AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers. - Wikidata - wikimedia - TriplyDB

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

http://www.wikidata.org/entity/Q34623325

about

Aurora kinase A in gastrointestinal cancers: time to target Functional Significance of Aurora Kinases-p53 Protein Family Interactions in Cancer Inhibition of mitotic Aurora kinase A by alisertib induces apoptosis and autophagy of human gastric cancer AGS and NCI-N78 cells.Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth.Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer.Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.Kinase signaling and targeted therapy for primary myelofibrosis.An update on the pharmacokinetics and pharmacodynamics of alisertib, a selective Aurora kinase A inhibitor.Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.Activation of EIF4E by Aurora Kinase A Depicts a Novel Druggable Axis in Everolimus-Resistant Cancer Cells.Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS STAT3 and STAT5A are potential therapeutic targets in castration-resistant prostate cancer.STAT3 down-regulation induces mitochondria-dependent G2/M cell cycle arrest and apoptosis in oesophageal carcinoma cells.Down-regulation of STAT3 induces the apoptosis and G1 cell cycle arrest in esophageal carcinoma ECA109 cells.The Association Between AURKA Gene rs2273535 Polymorphism and Gastric Cancer Risk in a Chinese Population MASTL induces Colon Cancer progression and Chemoresistance by promoting Wnt/β-catenin signaling

P2860

Q26864277-DD90FD28-E222-47F7-A8BF-8EB33ADEA575 Q28071615-C8C9F39F-8C51-4E83-A94E-9D8425EB0CAD Q34982418-3032CD9B-BE22-4D55-A377-D425F670F66E Q35374753-29353F3A-480D-4E33-A95C-31C7FCF21941 Q38369000-0A55B500-E847-4BDB-ABFA-8450CC6E7143 Q38527414-709727E3-60E9-4CFE-A1FA-C3FE54795300 Q38775472-7D10C14F-8EFC-456E-949F-158330B8B78C Q38783162-59898E8A-793A-4CED-8359-F410024C9645 Q38833185-86D49D04-8E50-44B0-ABE1-11C23453E5EF Q39028389-480B4F87-0FFD-419B-8CCC-AEC750BB3E62 Q42117867-0ACE80A8-45D4-49C4-AF8E-E7E2732B8E23 Q47110097-6B5D998E-57DB-4946-9F37-D7982E9F12FE Q51038402-AF24BE89-3286-4F30-A519-9F9FC2808F8F Q52595261-990F72B6-9E73-4617-B7BF-5A299B1E816D Q58769257-BCF09E48-9745-467C-B98D-CB90FD06CB2B Q58805925-67487F1F-8BED-4DA2-81B1-27A6DF1D405F

P2860

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

http://www.wikidata.org/entity/Q34623325

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@ast

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@en

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@nl

type

label

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@ast

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@en

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@nl

prefLabel

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@ast

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@en

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@nl

P1433

Q34623325-DD97878C-CFF6-4C3F-B473-2610743988C6

P1476

Q34623325-DF14CD90-EB84-40B0-B967-8C71A011BC48

P2093

Q34623325-0D0C42CB-59C4-4E41-BECE-C5AFAD3A29E1

Q34623325-21CD8283-6C00-4A6B-8086-5AEFCC1A6E34

Q34623325-6E50EFB8-F5DB-43D2-9051-9D2F0BC84B89

Q34623325-701069C5-B7D5-4867-8804-A10DE830985C

Q34623325-D0C07E18-3209-427F-8344-EFC81B644BED

P2860

Q34623325-010CF686-8699-41AA-8FBD-A7C38621BC94

Q34623325-03D9073A-04C5-4BDB-8540-43DA8180702C

Q34623325-0557CFDA-F05B-4743-8F4E-F231C05004F9

Q34623325-05FDC0D5-8063-4D22-B014-DE0B2FD2B607

Q34623325-09BFBDDD-44BA-4C85-9525-FC7B17D91F15

Q34623325-1035F21F-FE27-4A8C-B994-70C38A0EEE4B

Q34623325-11183234-34D6-4696-83FF-66114A529B7D

Q34623325-12AD7778-3088-407D-8DA1-E1F76E71741F

Q34623325-12D29407-D175-4A61-9B29-3B7A909EBE35

Q34623325-14A4297A-2376-473E-AFE1-66EEF5E8400D

P304

Q34623325-9D2B006B-5D67-4DE7-B978-B68E75224A93

P31

Q34623325-3ED7C349-A14C-42E3-9D70-40E35AF3B418

P356

Q34623325-C1ABE1D8-64C4-4599-8070-44B91181A1A1

P433

Q34623325-411BCC91-7B6A-46D7-9B76-B255AA1512E0

P478

Q34623325-4293234E-72C6-4EAA-932D-D2FD095CDAC2

P577

Q34623325-10922B10-9060-49FA-8675-61E034101DE2

P698

Q34623325-4FACEE24-C1E3-40BF-BA77-7FE157993B2E

P932

Q34623325-C72CF8E6-857D-418D-8AB9-74D54F5BE57E

P356

J.MOLONC.2014.05.012

P1433

Molecular Oncology

P1476

AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers.

@en

P2093

Abbes Belkhiri

http://www.w3.org/2001/XMLSchema#string

Ahmed Katsha

http://www.w3.org/2001/XMLSchema#string

Janet Arras

http://www.w3.org/2001/XMLSchema#string

Mohammed Soutto

http://www.w3.org/2001/XMLSchema#string

Wael El-Rifai

http://www.w3.org/2001/XMLSchema#string

P2860

Aurora kinase-A inactivates DNA damage-induced apoptosis and spindle assembly checkpoint response functions of p73

Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma

The aurora kinase A inhibitor MLN8237 enhances cisplatin-induced cell death in esophageal adenocarcinoma cells

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

STATs in cancer inflammation and immunity: a leading role for STAT3

Gastric cancers overexpress S100A calcium-binding proteins.

A kinase inhibitor screen identifies small-molecule enhancers of reprogramming and iPS cell generation.

STAT3 can be activated through paracrine signaling in breast epithelial cells.

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.

Phase II study of alisertib, a selective Aurora A kinase inhibitor, in relapsed and refractory aggressive B- and T-cell non-Hodgkin lymphomas

P304

1419-1428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLONC.2014.05.012

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24953013

http://www.w3.org/2001/XMLSchema#string

P932

4254172

http://www.w3.org/2001/XMLSchema#string